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force, Path control, and FreeD
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Abstract
Background: Robot-assisted gait therapy is increasingly being used in pediatric neurorehabilitation to complement
conventional physical therapy. The robotic device applied in this study, the Lokomat (Hocoma AG, Switzerland), uses a
position control mode (Guidance Force), where exact positions of the knee and hip joints throughout the gait cycle are
stipulated. Such a mode has two disadvantages: Movement variability is restricted, and patients tend to walk passively.
Kinematic variability and active participation, however, are crucial for motor learning. Recently, two new control modes
were introduced. The Path Control mode allows the patient to walk within a virtual tunnel surrounding the ideal
movement trajectory. The FreeD was developed to support weight shifting through mediolaterally moveable
pelvis and leg cuffs. The aims of this study were twofold: 1) To present an overview of the currently available
control modes of the Lokomat. 2) To evaluate if an increase in kinematic variability as provided by the new
control modes influenced leg muscle activation patterns and intensity, as well as heart rate while walking in
the Lokomat.
Methods: In 15 adolescents with neurological gait disorders who walked in the Lokomat, 3 conditions were
compared: Guidance Force, Path Control, and FreeD. We analyzed surface electromyographic (sEMG) activity
from 5 leg muscles of the more affected leg and heart rate. Muscle activation patterns were compared with
norm curves.
Results: Several muscles, as well as heart rate, demonstrated tendencies towards a higher activation during
conditions with more kinematic freedom. sEMG activation patterns of the M.rectus femoris and M.vastus medialis showed
the highest similarity to over-ground walking under Path Control, whereas walking under FreeD led to unphysiological
muscle activation in the tested sample.
Conclusions: Results indicate that especially Path Control seems promising for adolescent patients undergoing
neurorehabilitation, as it increases proximal leg muscle activity while facilitating a physiological muscle activation.
Therefore, this may be a solution to increase kinematic variability and patients’ active participation in robot-assisted gait
training.
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Background and technical introduction
Walking disorders are a common problem in patients with
neurological impairments. Accordingly, robot-assisted
therapy is used in neurorehabilitation to increase the dose
of task-specific gait training. The most frequently applied
gait orthosis is the Lokomat (Hocoma AG, Volketswil,
Switzerland). The Lokomat is a robotic exoskeleton, used
in rehabilitation centers to complement conventional ther-
apies since it appears to be a feasible and promising thera-
peutic tool for adults as well as for children and
adolescents [1–5]. Nevertheless, its effectiveness is being
controversially discussed. Some studies concluded that
robot-assisted therapy is superior to manual or conven-
tional therapy in patients with stroke [6, 7] while other
studies came to the opposite conclusion for stroke survi-
vors as well as for patients with spinal cord injury [8–11].
Recent research, especially with patients following stroke,
pointed out that a combination of robot-assisted therapy
and conventional physical therapy might be the most
promising solution [1, 3]. Thereby, robotic devices could
offer a safe, simplified, and supportive environment for the
therapy while also supporting visual feedback and haptic
learning, which is thought to lead to the best learning per-
formance of movements [12, 13]. However, clinical routine
and scientific evidence showed that the provision of such a
supportive environment comes with a price: the full and
constant guidance of the robot often leads to patients being
passive which might result in reduced muscle activity
[14–16]. It furthermore limits active participation, dy-
namic walking pattern adaptation, variability in movements,
and the possibility to make errors. These are all important
factors for motor learning and for improving gait perform-
ance [16–20]. Patients have to train in many different ways
and as often as possible (“repetition without repetition”)
[21]. In an animal study, Cai et al. [22] demonstrated that
spinal cord-transected mice showed a faster and a more
distinct recovery when they trained with variable compared
to fixed robotic trajectories for movements of the hind
limbs. Although these results are encouraging, it remains
unclear if these findings also translate to humans. Anyhow,
improvement of rehabilitation robots, especially for func-
tionally more advanced patients, is essential.
Consequently, new approaches have been developed
that take into account the patient’s functional ability.
These are based on the technical reduction of the sup-
portive force to ensure active participation of the patient
as well as to increase the possible variability of the
movement [23]. The following paragraphs provide a
comprehensive overview of the commercially available
control soft- and hardware of the Lokomat.
Control modes of the Lokomat
Currently, two different commercially available modes
exist to quantify and modify the amount of support the
patients receive during walking: Guidance Force and
Path Control.
Guidance force
The original mode Guidance Force can be set from 0 to
100%. Walking at 100% guidance (impedance control)
corresponds to a position-controlled mode, i.e. there is a
predetermined cyclical movement trajectory for the knee
and hip in the sagittal plane from which no deviation is
possible [24–26]. Therefore, theoretically, no active par-
ticipation of the patient is needed. From a clinical per-
spective, this might be a solution for severely affected
patients [27].
As soon as the Guidance Force parameter is <100%,
the impedance is reduced, which means that the restor-
ing forces that push the patient’s hip and knee towards
the reference trajectory are reduced. Therefore, small de-
viations from the given trajectory are allowed, and the
greater the deviation is, the larger becomes the force
that pushes the patient back to the trajectory (like a
spring). When Guidance Force is set to 0%, the Lokomat
will not provide support for the patient’s movements
and should only compensate for robotic dynamics (grav-
ity and Coriolis forces) but not for inertia. The downside
of robotic devices using classical impedance control is
the temporal restriction in walking. They hinder the pa-
tients to vary their timing without losing control in
space and to experience kinematic variability in a safe
and supporting way [26].
Path control
The first solution to solve this issue with the limited
variability in kinematics of exoskeleton robots was pro-
posed by Cai et al. [28] in mice, and it was adapted to
stroke patients by Banala et al. [29]. A virtual tunnel was
implemented, in which the patients could modify their
trajectories with a certain spatial and temporal freedom
while a moving force supported them to conduct the
movement in accordance with the treadmill speed. For
the Lokomat, the first version of this strategy called Path
Control was implemented by Duschau-Wicke et al. [26],
and it has been commercially implemented in all Loko-
mat Pro version 6.0 devices since 2014. In Path Control,
kinematic variability is offered by a torque field tunnel
in joint space which controls the spatiotemporal charac-
teristics of the gait pattern by applying corrective tor-
ques if the leg position is outside of the tunnel. The
width of the tunnel can be set to narrow (small devia-
tions allowed), middle, and wide (large deviations
allowed). The “Support Force” (0–100%) assists the pa-
tient with the step timing. It provides an extra “wind” of
force in the direction of the gait trajectory and can help
the patient temporally to overcome weakness. It also re-
duces the uncompensated inertia of the robot (Fig. 1, for
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technical details, see [26, 30, 31]). Since Guidance Force
and Path Control are superimposed mechanisms, the
Guidance Force mode must be set to lower than 30% to
enable Path Control to unfold its advantages.
Only a few studies have investigated Path Control in
adult humans. They could show an increased active par-
ticipation [30], a more physiological gait pattern [27],
and improvements in clinical gait parameters when
training with Path Control instead of Guidance Force
[14, 32]. So far, no study exists that implemented the
Path Control mode in children and adolescents with
neurological gait disorders.
FreeD
Up to this stage, the pelvis and its motions were con-
strained to the sagittal plane and also the leg cuffs were
fixed preventing lateral movements during Lokomat
walking. However, lateral pelvic displacement is physio-
logical and necessary for a natural gait pattern [33]. Dif-
ferent studies with robot-assisted devices concluded that
restrictions in pelvic motions severely affect gait dynam-
ics [34] and alter muscle activation patterns [8, 15] and,
therefore, should be avoided.
In October 2014, a new module for the Lokomat was
introduced: The FreeD. With this hardware and software
approach, the pelvis is now movable in the frontal plane
to a lateral translation of up to 4 cm (per side) and in
the transversal plane to a pelvic rotation of up to 4° (per
side). Additionally, the cuffs have a laterally movable
range (Fig. 2). This should support the natural lateral
pelvis displacement as well as weight shifting during
walking and might enable an additional balance training
[35] which would be useful since balance is often par-
ticularly affected in patients with neurological disorders
[34]. Another study showed that with rhythmic weight-
shifting training, gait performance in children with spas-
tic diplegic cerebral palsy could be increased [36].
Therefore, the FreeD might be a promising renewal for
robot-assisted gait training, “making the walking pattern
more physiological and more natural” [35].
Although a substantial amount of work has been done
during the last years in this rapidly growing field, the
question concerning the most effective control algorithm
for robot-assisted gait training still remains open [23].
Therefore, the aim of this study was to investigate the
new control modes Path Control and FreeD in children
and adolescents with neuromotor disorders and to com-
pare them to Guidance Force. To examine the influence
of these control modes on sEMG parameters during
Lokomat walking, we formulated the following research
questions: (1) Quantitative gait analysis: Does training in
the Lokomat under a condition with more kinematic free-
dom leads to an increase in muscle activity and heart rate
(Guidance Force < Path Control < FreeD)? and (2) Quali-
tative gait analysis: Does a change in muscle activity go
along with maintaining a physiological gait pattern?
Methods
Participants
Thirty-seven in- and out-patients of the Rehabilitation
Center for Children and Adolescents in Affoltern am
Albis were recruited between April 2015 and 2016 to
join the study. They met the following inclusion criteria:
(1) a neurological impairment resulting in a gait dis-
order, (2) no contraindications for the training in the
Lokomat (see [37]), (3) able to communicate fear, dis-
comfort or pain, and (4) understanding simple instruc-
tions, (5) a femur length of 35-47 cm (currently, Path
Control is only available for the adult Lokomat orthosis)
and (6) written informed consent of parents and adoles-
cents ≥14 years and assent of children <14 years. Sixteen
children and adolescents agreed to participate in the
study. Twenty-one disagreed due to different private rea-
sons (e.g. distance for traveling to the clinic, busy at
school). Patients were characterized by age, daily life
mobility aids, and the Gross Motor Function Classifica-
tion System (GMFCS level, only available for children
Fig. 1 Guidance Force and Path Control mode. Left: the Guidance Force mode. Right: Path Control mode. The orange dots indicate the required
position in the sagittal plane at a specific time point in the gait cycle (spatiotemporal placement). The yellow arrows represent the forces that
push the patient to the reference trajectory (Guidance Force) or the tunnel (Path Control). The additional dots on the right side indicate several
possible positions, symbolizing the kinematic variability. Images courtesy of Hocoma AG
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and adolescents with cerebral palsy [38]). Measurements
of the Manual Muscle Test [39] and the Selective Con-
trol Assessment for the Lower Extremity [40] were
performed to determine the more affected leg of the pa-
tients. The completed STROBE checklist (see Additional
file 1) and source data (see Additional files 2, 3, 4, and
5) can be found in the appendix.
Gait training robot and control modes
Detailed information about the used Lokomat device
can be found elsewhere [24, 41, 42]. In this study, the
Lokomat exoskeleton was adapted to every patient indi-
vidually, ensuring that walking in the robot was as com-
fortable as possible. Training parameters were selected
by clinical experience [43]. The treadmill was set to a
comfortable speed for the participant (initial speed was
always 1.8 km/h and participants could then change it in
small steps until they found it to be comfortable). Aver-
age speed ± standard deviation was 1.96 ± 0.15 km/h
and it was kept constant during the measurements. The
amount of body weight support was set to 30% of the
child’s body weight. Patients had to wear elastic foot
lifters to support toe clearance during swing phase and a
mirror provided visual feedback of the walking pattern.
To allow for a warm-up (all participants had prior Loko-
mat experience), each patient walked about 10 min with
100% Guidance Force (baseline walking setting). After
this familiarization period, all patients reported that
walking in the device felt comfortable and that the kine-
matic trajectory was easy to follow.
Experimental design
The exact device settings for the three experimental con-
ditions are depicted in Fig. 3. The order of the conditions
was randomized [44], and each condition lasted 2 min.
Data recording occurred during these 2 min, and stan-
dardized instructions were given before and throughout
the testing (see Additional file 7). Between the conditions,
a break of 1 min with the baseline walking setting allowed
the patient to relax for a moment.
As already mentioned in the technical background,
Guidance Force and Path Control are superimposed
Fig. 2 Lateral translation and transverse rotation of FreeD. Left: Lateral pelvis movement and rotation during physiological walking. Middle:
Possibility of lateral pelvis and leg translation with the new FreeD. Right: Possibility of pelvis rotation with the new FreeD. Images with courtesy of
Hocoma AG
Fig. 3 Study overview. Overview of the three different control modes and test conditions. The order was randomized and every condition lasted
two minutes with a one minute break in between
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control modes, which optionally can be combined with
the FreeD module. Therefore, condition GF was a stand-
ard therapy setting of 100% Guidance Force (see blue
box in Fig. 3). Condition PC was a setting with higher
kinematic freedom (Path Control), whereby Guidance
Force was set to 0% to allow Path Control to completely
take over (see green box in Fig. 3). To max out the Loko-
mat’s kinematic freedom, condition FD was a combin-
ation of Path Control and FreeD, whereby the pelvis and
cuffs were moveable (pelvis free up to 4° of rotation and
2 cm lateral shift to each side; cuffs free, see yellow
box in Fig. 3). In both, Path Control and FreeD, the
Support Force within Path Control was set to 100%
(see green and yellow boxes in Fig. 3).
The study consisted of further sub-conditions where
the Support Force during Path Control was modulated
(comparable to [31]), and the degrees of freedom (pelvis
and cuffs) of the FreeD were modified, but to remain
concise, they are not part of this manuscript.
Measurements
The measurements took place at the Rehabilitation Center
for Children and Adolescents in Affoltern am Albis,
Switzerland. The experimental protocol was in accordance
with the Declaration of Helsinki [45] and was approved by
the Ethical Committee of the Canton Zurich, Switzerland.
Activity of the following 5 muscles of the more affected
leg was determined by surface electromyography (sEMG):
the M.rectus femoris (RF), M.vastus medialis (VM), M.bi-
ceps femoris, long head (BF), M.tibialis anterior (TA) and
M.gastrocnemius lateralis (GL). The surface electromyog-
raphy recordings were done with the Wireless TeleMyo
DTS system and the MyoResearch XP software (Noraxon
Inc., Scottsdale, USA). The system was time-synchronized
with a video camera that was positioned beside the child’s
measured leg to identify gait cycle events. The placement
of the sEMG electrodes was always done by the same
therapist for all measurements adhering as closely as pos-
sible to the SENIAM guidelines [46] (Fig. 4). The skin was
prepared by shaving and applying an abrasive paste and
then self-adhesive Ag/AgCl snap electrodes (Noraxon
Dual Electrodes, 10 mm diameter and 20 mm inter-
electrode distance, Noraxon Inc., Scottsdale, USA) were
positioned. The quality of the sEMG signals was visually
inspected during the familiarization period as well as dur-
ing the measurements to ensure that the electrodes were
correctly placed and to exclude movement artifacts during
walking.
Furthermore, a heart rate belt (Polar RS800CX Pro
Training, sampling frequency 0.2 Hz, Polar Electro Oy,
Kempele, Finland) recorded the heart rate during train-
ing. As the Guidance Force condition acted as theoret-
ical baseline of physiological walking, we wanted to
know if participants could maintain this physiological
pattern when switching to other control strategies.
Therefore, after each walking condition (see Fig. 3), the
therapist scored the walking pattern as “physiological”
(=1) or “not physiological” (=0). This decision was sub-
jective, but it was mainly based on the fulfillment of the
following factors: timing of heel strike, knee extension in
stance phase, step symmetry, step length, toe clearance,
and rhythm. If two or more factors were conspicuous,
the performance was rated as “not physiological”. Add-
itionally, the patient scored the experience as “comfort-
able” (=1) or “not comfortable” (=0), as child-friendly
terms for “physiological” and “not physiological”. This
was differentiated from signs or statements of physical
discomfort or even pain, which led to a temporary halt
of the experiment.
Data analysis
sEMG data were rectified and smoothed by a Root Mean
Square with a time window of 100 ms. For the sEMG-
data analysis, 10 strides [47] after 30s of the start of each
condition were analyzed. The markers for heel strike
and toe off were set automatically by the program. Every
single marker was controlled and checked visually with
the synchronized video recording and adjusted manually
if necessary. Afterward, the sEMG data were exported to
Matlab (Matlab 7.1, the MathWorks Inc., Natick MA,
USA). For the analysis investigating quantitative changes
in sEMG activity, the sEMG of the 10 stance- and swing
phases of each muscle for every condition of each pa-
tient were averaged. Then, they were merged and time-
normalized to a 100% gait cycle (1000 samples).
For the analysis investigating qualitative changes in
sEMG activity, we took the sEMG individual time-
Fig. 4 sEMG electrodes placement. The placement of the electrodes
(according to the SENIAM guidelines, [46]). Left (from top to bottom):
M.rectus femoris, M.vastus medialis, M.tibialis anterior. Right (from top
to bottom): M.biceps femoris long head, M.gastrocnemius lateralis
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normalized averaged profile of each muscle for every con-
dition. These gait curves were then amplitude-normalized
to its maximal value (max. value = 100%). Afterwards, we
took the mean gait cycle over all participants per condi-
tion to generate grand-averaged gait cycle profiles for each
muscle per condition. Based on these grand averages, we
determined “On-”and “Off-phases” for each muscle. A
muscle was considered to be ‘on’ if its activity exceeded a
threshold, which was set at the minimum amplitude of
the sEMG grand average per muscle plus two standard de-
viations (SD) (adapted from [48]). Then, these on- and
off-phases were compared to the on- and off-phases of
sEMG norm curve data from 87 typically developing chil-
dren from Chang et al. [48], digitized with the WebPlotDi-
gitizer (retrieved from [49]). Comparisons were made with
two metrics: (i) the Spearman correlation coefficient that
indicates the similarity with the norm curve; and (ii) the
percentage of overlap as an indicator for the “normality”
of the muscle activation pattern. It was calculated as:
correct ON overlap %½ þcorrect OFF overlap
correct ON overlap %½ þfalse ON overlap %½ þcorrect OFF overlap %½ þfalse OFF overlap %½ 
For the heart rate, the values for the 2 min were aver-
aged for each condition.
Statistics
The statistics were done with IBM SPSS Statistics 22 (IBM
Corporation, Armonk, NY, USA). Data were checked for
normal distribution with the Shapiro-Wilk test together
with Q-Q-plots and histograms. Because most of the data
were not normally distributed, subsequent qualitative and
quantitative analyses were done with non-parametric tests
(Spearman correlations, Friedman- and Wilcoxon-tests).
The significance level was set at α = 5%. Post-hoc correc-
tions for multiple testing were done by applying False Dis-
covery Rate corrected p-values (FDR, [50]). Additionally,
effect sizes were calculated and scored according to
Cohen’s benchmarks (d = 0.2 is small, d = 0.5 is medium,
and d = 0.8 is considered a large effect size, [51]). The cor-
relations of the sEMG comparisons were interpreted as
follows (adopted from Evans, [52]): r < 0.20, “very weak”;
0.20–0.39, “weak”; 0.40–0.59, “moderate”; 0.60–0.79,
“strong” and 0.80–1.00 “very strong relationship”.
Results
Fifteen patients (5 girls, 10 boys) with a mean age of
16 ± 2y completed the trial. Details about the patients’
characteristics are listed in Table 1. In one participant,
the measurements had to be stopped immediately after
the beginning for safety reasons (patient ID 13), as the
therapist noted during the robot-walking familiarization
period that the patient would not be able to walk with
less than 100% Guidance Force.
Since some of the participants had to wear lower leg
orthoses for ankle-stabilization, we had missing data of
the M.tibialis anterior for 2 participants and the
M.gastrocnemius lateralis for 3 participants, respectively.
Quantitative changes in sEMG activity and heart rate
We found an increase in quantitative muscle activation
in several muscles when the kinematic freedom of the
Lokomat was enlarged. Significant group differences be-
tween the three conditions could be found for the
M.rectus femoris (P = 0.038), the M.vastus medialis
(P = 0.004) and the M.tibialis anterior (P = 0.018). Heart
rate did not reach significant results but a trend could
be detected (P = 0.085). sEMG amplitudes, the heart
rate, and the p-values of the 3 conditions and the five
muscles are presented in Fig. 5.
Additional file 7: Fig. S1 shows that the chosen proto-
col was adequately timed to approximately allow heart
rate to reach a steady state during the conditions and re-
turn to baseline during the breaks.
Significant differences in quantitative muscle activation
were found for M.rectus femoris, M.vastus medialis and
M.tibialis anterior. Pairwise post-hoc comparisons with
effect sizes of the different conditions are presented in
Table 2.
Qualitative changes in sEMG activity and walking patterns
The grand-averaged gait cycle profiles for each muscle
and each condition are displayed in Fig. 6 together with
reference curves of normally developing children
adapted from Chang et al. [48].
Focussing on the therapist’s and patient’s scorings, the
following results could be observed: During the Guidance
Force condition, the therapist scored the gait pattern as
“physiological” for all 15 patients while 13 patients rated
the condition to be “comfortable” (15/13). These numbers
were 8/9 during Path Control and 7/10 during FreeD
motion, respectively. Apparently, all of the patients walked
physiologically during the Guidance Force condition,
whereas fewer patients were scored with a physiological
gait pattern during Path Control and FreeD conditions.
Table 3 summarizes the correlations and overlaps of the
sEMG patterns with the norm curves and presents the
therapist’s and patients’ scorings.
Discussion
Quantitative changes in sEMG activity and heart rate
Our study investigated changes in muscle activity levels
and patterns induced by two new hard−/software ap-
proaches which were developed to increase patients’
kinematic variability. In general, we could show partially
significant increases in muscle activity and heart rate
from the condition Guidance Force to Path Control (ex-
cept for M.gastrocnemius lateralis) and from Path Con-
trol to FreeD motion (except for M.rectus femoris and
heart rate) (Fig. 5 and Table 2). This is in line with
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earlier results from Duschau-Wicke et al. [30] and
Schück et al. [27], where patients walked more actively
under the Path Control mode. However, in contrast to
the results from Schück et al. [27], our results could de-
tect only partially significant trends. This distinction could
be explained by the different patient population or by the
fact that their controls walked on a treadmill whereas we
compared our data with norm curves of free overground
walking. Another reason might be that we evaluated only
one training session whereas they analyzed the change over
Table 1 Patients' characteristics
ID Age (years) Main diagnosis (GMFCS Level) More impaired leg Walking speed (km/h) Daily life mobility aids
1 19 CP, bilateral ataxic (III) right 2.2 Dorsal walking frame for longer distances
2 19 Hereditary spastic paraplegia right 2.2 None
3 14 CP, bilateral ataxic (II) left 2.0 Dorsal walking frame, ankle-foot orthoses
4 14 ABI a (unilateral paresis) left 1.9 Foot-up orthosis
5 16 ABI a (unilateral spastic paresis) left 2.0 None
6 19 CP, bilateral spastic (III) right 2.0 Crutches, orthopedic shoes
7 13 CP, bilateral spastic (II) left 2.0 Foot-up orthosis
8 15 MMC L3/L4 right 1.8 Crutches
9 16 CP, bilateral spastic (II) right 1.8 Ankle-foot orthoses
10 16 CP, bilateral spastic (III) left 1.9 Dorsal walking frame for longer distances,
ankle-foot orthoses
11 14 CP, bilateral spastic (III) right 2.1 Ankle-foot orthoses
12 20 ABI a (bilateral spastic paresis) right 1.8 None
13 19 CP c, bilateral spastic (IV) right 1.4 Wheelchair, ankle-foot orthoses
DROP-OUT
14 15 CP, unilateral spastic (I) left 1.8 None
15 14 ABI a (unilateral spastic paresis) left 1.8 None
16 12 ABI b (unilateral paresis) left 2.1 None
Abbreviations: CP cerebral palsy, GMFCS Gross Motor Function Classification System [38], MMC Meningomyelocele (spina bifida), ABI acquired brain injury,
a= measurements more than 2.5 years after event, b= measurements 2 months after event. cID 13 was excluded because the measurements had to be stopped
shortly after the beginning
Fig. 5 sEMG amplitudes and heart rate during walking under the three different control modes. To facilitate a comparison, the conditions were
normalized by setting the highest median sEMG activity value of the three walking conditions for each muscle to 100% (and the same for heart
rate). To improve visualization, outliers are not shown in the figure. However, they are included in the statistical analyses. P-values of the Friedman
tests for each muscle and for heart rate are shown below the graph. Statistically significant data are indicated in bold
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16 training sessions. Furthermore, van Kammen et al. [53]
concluded that a higher guidance force in the Lokomat in
general reduced the amplitude of muscle activity (M.biceps
femoris, M.gastrocnemius medialis), and that this effect
depended on body weight support and gait speed. How-
ever, they observed this effect only in muscles related to
stability and propulsion and not leg loading (M.vastus
lateralis) and foot clearance (M.tibialis anterior). In general,
only small effect sizes could be found in the analysis of
quantitative changes in sEMG and heart rate, except for
the M.vastus medialis, where the significant differences in
muscle activation were supported by a moderate effect size
(i.e. -0.56, Table 2). It should be mentioned that the eco-
nomics of a neurologically impaired gait (especially in cere-
bral palsy) are often affected by a poor biomechanical
alignment. This means that a patient with cerebral palsy
commonly walks with a high sEMG activity and heart rate.
Therefore, a higher sEMG activity should not be a general
goal of a therapy. Rather, it must be interpreted in combin-
ation with a pattern analysis.
Qualitative changes in sEMG activity and walking patterns
A deeper insight in the sEMG grand-averaged gait cycle
profiles (Fig. 6) revealed that the interpretation of the re-
sults is not as simple as it seems. The normal activity of
M.rectus femoris (Fig. 6a) has two active phases, one at
the end of preswing till midswing (55–80% Gait Cycle
(GC) [48]) and the other from terminal swing till the
end of loading response (90–15% GC) with a clear peak
in loading response. In our study, walking under Path
Control revealed the best overlap (70%) with these active
and passive phases as well as a moderate correlation
(r = 0.57) with the pattern. This finding stands in con-
trast to Duschau-Wicke et al. [54] where M.rectus
femoris presented an unphysiological gait pattern during
walking with Path Control.
The M.vastus medialis normally activates in terminal
swing till early midstance (86–20% GC, Fig. 6b). At first
sight, the pattern during walking under Guidance Force
in our results looks the most similar to the norm curve,
but it shows an abnormal active peak in late midstance.
This is in contrast to the percentage overlap, which was
best for the Path Control condition, i.e. 70%. This high
number has originated from the overlap of an active
phase in initial contact and loading response (early
stance phase) and a passive phase from midstance to the
end of midswing. It might be confusing that the norm
curve maps an additional preswing and initial swing ac-
tivity (45–65% GC, * in Fig. 6b), which is being ignored
in the physiological activity range determined by Chang
et al. [48]. This additional activity (in this study during
walking under Guidance Force and FreeD) might stem
from a co-contraction for the stabilization of the knee
before entering the swing phase and was also reported
in previous studies [55, 56]. If this additional peak had
been included by Chang et al. [48], walking under
Table 2 Comparison of the sEMG amplitudes between conditions. P-values of the Wilcoxon tests before and after FDR correction
for multiple testing and effect sizes are shown
Comparisons p-values of the Wilcoxon test FDR corrected p-values Effect sizes
M.rectus femoris GF - PC 0.100 0.150 −0.30
GF - FreeD 0.061 0.150 −0.34
PC - FreeD 0.496 0.496 −0.13
M.vastus medialis GF - PC 0.173 0.173 −0.25
GF - FreeD 0.020 0.030 −0.43
PC - FreeD 0.002 0.006 −0.56
M.biceps femoris GF - PC 0.955 0.955 −0.01
GF - FreeD 0.363 0.545 −0.17
PC - FreeD 0.125 0.375 −0.28
M.tibialis anterior GF - PC 0.133 0.199 −0.30
GF - FreeD 0.023 0.069 −0.45
PC - FreeD 0.701 0.701 −0.08
M.gastrocnemius lateralis GF - PC 0.209 0.582 −0.26
GF - FreeD 1.000 1.000 0.00
PC - FreeD 0.388 0.582 −0.18
Heart rate GF - PC 0.069 0.104 −0.33
GF - FreeD 0.047 0.104 −0.36
PC - FreeD 0.427 0.427 −0.15
Abbreviations: FDR False Discovery Rate [50], GF Guidance Force, PC Path Control. Statistically significant data are indicated in bold
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Fig. 6 (See legend on next page.)
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Guidance Force would have gained the best agreement
between the two patterns (which is already visible with
the current strong correlation r = 0.64).
The active range of M.biceps femoris is from the end
of midswing till terminal stance (80–50% GC, Fig. 6c).
In our study, this was best represented by both Guid-
ance Force and Path Control with a moderate correlation
(r = 0.46) and an overlap of 64%.
M.tibialis anterior is characterized by two peaks of
activity, one from preswing till midswing (55–80%
GC) and a second in terminal swing until the end of
loading response (90–15% GC, Fig. 6d). In this
muscle, both walking under Guidance Force as well
as under Path Control could reach an acceptable
overlap (68% and 66%, respectively), with moderate
correlations. An abnormally low sEMG activity in ter-
minal swing as detected in our data was also reported
in other studies with children [56, 57] and could stem
from the use of foot lifters [15].
The M.gastrocnemius lateralis normally presents activ-
ity from the end of the loading response to the middle
of preswing (10–55% GC), with a clear peak at 40% GC
(Fig. 6e). Our data could not detect this clear pattern
with only very weak correlations during Guidance Force
(r = 0.14) and Path Control (r = 0.06). Main functions of
this muscle are to extend and stabilize the knee during
stance and to induce the push off. When walking in the
Lokomat, the cuffs and the robot itself take over these
parts. A pattern without clear activity peaks of the
M.gastrocnemius is also known from treadmill walking,
where the push off is not as clear due to the moving
treadmill [56]. An early onset of swing and a prolonged
activity in stance are known as the plantar flexion-knee
extension couple to control the second rocker and an
Table 3 Overview of the sEMG correlations and overlaps with the norm curves and subjective ratings of the therapist and patients
Guidance Force Path Control FreeD
Correlation Overlap Correlation Overlap Correlation Overlap
M.rectus femoris 0.30 61% 0.57 70% -0.57 20%
M.vastus medialis 0.64 43% 0.45 70% 0.30 36%
M.biceps femoris 0.46 64% 0.46 64% -0.28 31%
M.tibialis anterior 0.59 68% 0.53 66% -0.68 18%
M.gastrocnemius 
lateralis
0.14 61% 0.06 59% -0.50 28%
Sum of therapist’s 
rating
15 8 7
Sum of patient’s 
rating
13 9 10
Therapists had to score the patient’s walking under a specific condition as “physiological” (=1) or “not physiological” (=0); Patients had to score the walking under
a specific condition as “comfortable” (=1) or “not comfortable” (=0). The color codes are adapted in accordance to the interpretation for the correlations [52]: “very
weak” (or negative) and “weak” = white, “moderate” = light grey and “strong” = dark grey
(See figure on previous page.)
Fig. 6 Grand-averaged gait cycle sEMG profiles for each muscle and each condition. Linear envelope curves of the averaged gait cycle per
muscle show mean ± standard deviation of the norm curve (adapted from Chang et al. [48]) and the three different walking conditions: Guidance
Force (blue), Path Control (green) and FreeD (yellow). Muscle onset threshold was defined as 2 standard deviations above the minimum amplitude
of the mean curve over all patients for each muscle separately. Grey banners in the background indicate that the muscle is expected to
be “active” (= norm curve activity above the threshold); white banners in the background indicate that the muscle is expected to be
“passive” (= norm curve activity below the threshold), see Fig. 6a. Colored shadows indicate that the muscle during that timepoint in the
specific walking condition is active. Toe off time and shift from stance to swing phase is indicated with a vertical line ± one standard
deviation (dashed lines). The “correlation” value refers to the Spearman correlation of the pattern of that specific walking condition with
that of the norm pattern and “overlap” indicates the percentage of “activity” and “passivity” overlap of the pattern of that specific walking
condition with that of the norm curve. *According to Chang et al. [48], the M.vastus medialis is not active here, despite supra-threshold activity
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upright position [56]. In our data, this was observable in
Path Control and FreeD conditions.
In contrast to the norm data, our pattern curves lack
clearly discernible peaks. At this point, it must be men-
tioned that Chang et al. [48] generated their norm
curves by including only EMG patterns which showed
the typical one or two peaks in the expected period
(positive selection bias). It is obvious that the elimin-
ation of all other patterns resulted in curves with clear
peaks and clear active and passive phases. In contrast,
our grand-average profiles included all data. Therefore,
it is difficult to get good correlations with these norm
patterns, and we decided to add the overlap analysis.
Thereby, it is possible to observe windows of abnormal
activity, similarly to the work of van Kammen et al. [53].
This abnormal activity may indicate efforts e.g. to over-
come constraints from the robot [15, 16] or increased
balance needs [53, 58].
In summary, proximal leg muscle activity patterns did
have the best overlaps during walking under Path
Control, with also good patterns under Guidance Force.
Distal leg muscles showed conflicting outcomes. While
M.tibialis anterior generated quite good patterns con-
cerning correlation and overlap, weaker correlations
were found for M.gastrocnemius lateralis. Generally,
during the FreeD motion condition, all pattern correla-
tions were weak and mostly negative. However, FreeD
was the only condition, where significantly higher
muscle activity was found in the M.vastus medialis com-
pared to Guidance Force or Path Control. The higher
muscle activation could be a result of the efforts of the
patients, who tried to compensate (unphysiologically) for
too much kinematic freedom. Due to this kinematic
freedom, we initially assumed that FreeD could facilitate
physiological walking since patients would not be re-
stricted in their gait trajectory. Hidler and Wall [15] in-
dicated in their study that muscle activity patterns are
altered while walking under full guidance because pa-
tients work against the robot (M.rectus femoris, M.bi-
ceps femoris). According to Ayoagi et al. [59], it is
important for a natural human gait that robot-assisted
devices allow the leg to swing out to the parasagittal
plane and to allow the pelvis to rotate and to make a lat-
eral translation. However, it seems that patients were
unable to deal with the high kinematic freedom and
therefore performed with too much muscular activity in
an unnatural activation pattern to keep up the biomech-
anical alignment. It seems that this possibility to move
to the parasagittal plane was the biggest challenge for
our patients since the Guidance Force and Support
Force vectors only operate in the sagittal plane.
Consequently, not only the sEMG analysis revealed is-
sues with the kinematic freedom. Based on the therapist’s
rating we saw that not all of our patients could deal with
the additional kinematic freedom during Path Control and
FreeD and around half of the patients rated walking in
these conditions as “uncomfortable”. They developed an
unphysiological gait pattern and would have needed more
guidance from the Lokomat, or from the therapist through
instructions. Due to the standardized instructions during
the study (see Additional file 6), we refrained from this
permanent verbal input. Nevertheless, these results were
unanticipated since patients still received 100% Support
Force while walking with Path Control and FreeD. More-
over, patients reported very differently about their impres-
sion of the kinematic variability. While some of them
found the freedom comfortable, others felt unguided and
actively tried to deal with this variability. It seems clear
that these feelings depend on the skills of the individual
patient and these results are in line with the findings of
Duschau-Wicke et al. [30]. Therefore, a further analysis of
varying Support Forces may give additional information
about the effects on muscle activity, activation patterns,
and the rating of therapists and patients.
Clinical implications
For clinical practice in neurorehabilitation, it is import-
ant to train restorative rather than compensatory pat-
terns [56, 60]. Therefore, inducing physiological gait
patterns by training under Guidance Force or Path
Control might be the preferred method. Nevertheless,
our results reinforce the opinion that the therapist plays
a crucial role during robot-assisted gait training during
rehabilitation [43, 56]. The therapist has to decide indi-
vidually which control mode is reasonable for a training
with a specific patient. Certainly, this decision depends
also on the aim of the training. If the goal is to train a
specific, symmetric gait pattern (often the target in an
early phase of rehabilitation or in severely impaired pa-
tients) then the training should be performed using the
Guidance Force mode where the patient gets an exact
and symmetric, predetermined gait trajectory. If the goal
is for example to train muscle strength, endurance, joint
control, weight shifting, balance, or step variability, then
Path Control or even FreeD might be a good choice. The
therapist’s decision to choose one or the other training
option also depends on the duration with which a spe-
cific control mode is applied. A control mode with high
kinematic freedom might be selected to work on a spe-
cific impairment, however, it will be difficult for the pa-
tient to train with a physiological walking pattern for a
prolonged duration. In this case, the patient should get
frequent, intensive verbal instructions.
Limitations
Our patient group was a convenience sample and het-
erogeneous regarding diagnosis, age, level of cognition,
and skills. This may have increased the data variability
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and influenced the results, but the aim of this study was
to reflect clinical everyday life with neurological patients
where the population is very heterogeneous. Since the
sample size in this study is small, we should be cautious
in generalizing the results of this study to similar popu-
lation groups, even though the uniformity of Lokomat
therapy and the standardized measurement procedure
provide a highly reproducible setting. Accordingly, fur-
ther studies are needed to investigate disease-specific
patterns into further detail to get a finegrained impres-
sion about the effects of the different control modes on
the muscle activation patterns of patients with specific
neuromotor disorders.
We compared sEMG-patterns of patients with neuro-
motor disorders to those of a published sample of healthy
controls. While an intra-individual comparison would be
desirable, these patients are not able to generate a physio-
logical gait pattern overground. Therefore, our EMG data
might partially differ from the EMG norm data, e.g. re-
garding exact electrode placement or data preprocessing.
Additionally, we cannot exclude that the 10 min-long
warm-up phase with 100% Guidance Force influenced the
performance during the test conditions.
In our study, only adolescents could participate, as
Path Control and FreeD are only available for the adult
Lokomat exoskeleton. As soon as a pediatric version is
available, the study should be extended to children as
well. Furthermore, for safety reasons, the patients had to
wear foot lifters while walking in the Lokomat and it is
possible that this has influenced muscular activity, espe-
cially of the distal muscles.
Another limitation is that the treadmill speed in our
patients varied between 1.8–2.2 km/h to allow for com-
fortable walking. Since gait speed has an influence on
the gait pattern [61], treadmill speed was kept constant
throughout the whole experiment. Therefore, future
strategies to increase patients’ interactivity with robot
devices should combine the tested modes of this study
with approaches to adapt the treadmill speed according
to the patient’s intention [26, 62]. The results of FreeD
in this study were against our expectations, and further
research is necessary to clarify this topic. We assume
that the chosen settings of the control modes might have
overly affected the difficulties of the walking conditions
(e.g. Guidance Force set to 0% and Support Force to
100% in Path Control and FreeD, see Fig. 3). This is sup-
ported by the fact that Guidance Force had to be ad-
justed to 10% in 3 patients to enable 2 min of constant
walking. Nevertheless, the idea of the experiment was to
select 3 conditions with differing kinematic variability.
Further studies should test the FreeD in combination
with a bigger underlying Guidance Force (e.g. above
60%), which will most likely be used in a clinical setting.
Additionally, future studies should investigate changes of
gait pattern over time (e.g. over 15 min. Walking time
with the same conditions) and alterations/adaptations of
the gait pattern after several training sessions with new
technologies (including studies of effectiveness).
Conclusion
With this study, we could show that alterations in muscle
activity (amplitude and pattern) can occur when different
control modes are used during training with the Lokomat.
Therefore, it seems that patient-cooperative tools are able
to address the main point of criticism against robot-
assisted gait training: the passivity of the patient. Add-
itionally, especially with Path Control, patients can train
walking in an active and physiological way. Further studies
should clarify, why the FreeD as tested in this study seems
to be less applicable for physiologic walking in moderately
affected children and adolescents with neurological gait
disorders and which requirements patients must meet to
train physiologically also with FreeD. Furthermore, longi-
tudinal studies should be performed to address the effect-
iveness and long-term effects of these new control modes.
However, the therapist is still the most important factor
for evaluating and influencing the performance during
robot-assisted gait therapy. It is his/her responsibility to
guide the training process and to choose an adequate
training mode to reach patients’ individual aims and goals
of gait rehabilitation.
Additional files
Additional file 1: STROBE Statement checklist. (DOCX 20 kb)
Additional file 2: Source data sEMG Guidance Force. (XLSX 27966 kb)
Additional file 3: Source data sEMG Path Control. (XLSX 27288 kb)
Additional file 4: Standardized instructions. (DOCX 14 kb) Source data
sEMG FreeD. (XLSX 27602 kb)
Additional file 5: Source Data heart rate. (XLSX 107 kb)
Additional file 6: Standardized instructions. (DOCX 14 kb)
Additional file 7: Figure S1. Time course of heart rate during
conditions. Time course of the average normalized heart rate curves of
the 3 conditions. Thereby, the individual mean heart rate over the last
minute of the warm-up phase (regular walking with 100% Guidance
Force) served as an individual baseline (=100%) to which the longitudinal
curves were normalized. The analysis shows that a steady state was
reached after approximately 1 min and that the 1-min break was long
enough for the heart rate to return close to baseline. (TIFF 1906 kb)
Abbreviations
BF: M.biceps femoris; FDR: False Discovery Rate; GL: M.gastrocnemius lateralis;
GMFCS: Gross Motor Function Classification System; RF: M.rectus femoris;
SD: Standard deviation; sEMG: Surface electromyography; TA: M.tibialis
anterior; VM: M.vastus medialis
Acknowledgements
We thank the physiotherapist Sandra Ricklin (Rehabilitation Center Affoltern
am Albis, Switzerland), who made an important contribution to the data
acquisition, and Alexander Duschau-Wicke (Hocoma AG, Switzerland) who
provided technical support with the new hardware and software modes. A
special thanks goes to all patients and their parents for participating in the
study. We further acknowledge the Neuroscience Center Zurich (ZNZ).
Aurich-Schuler et al. Journal of NeuroEngineering and Rehabilitation  (2017) 14:76 Page 12 of 14
Funding
This research was financially supported by the “Mäxi” Foundation, the
Fondation Gaydoul, and the CRPP Neurorehabilitation of the Medical Faculty
of the University of Zurich, Switzerland.
Availability of data and materials
The datasets supporting the conclusions of this article are included within
the article and its additional files.
Authors’ contributions
TA: Research project conception and execution, data acquisition review and
critique, manuscript writing. FG: Research project organization and execution,
data acquisition, statistical analysis, writing of the first draft. HvH: Research
project conception, statistical analysis review, manuscript review. RL: Research
project conception, statistical analysis, manuscript review and critique. All
authors approved the final manuscript.
Ethics approval and consent to participate
This study was approved by the Cantonal Ethics Committee of Zurich
(reference number KEK-ZH-Nr. StV. 07/07). All participants ≥14 years and all
legal guardians gave written informed consent to participate, participants
<14 years provided assent.
Consent for publication
All authors have approved the manuscript for submission. All participants and/
or their legal guardians gave written informed consent to publish these data.
Competing interests
The authors declare that they have no competing interests and there are no
financial competing interests to declare in relation to this manuscript.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published
maps and institutional affiliations.
Author details
1Rehabilitation Center Affoltern am Albis, Children’s University Hospital
Zurich, Muehlebergstrasse 104, CH-8910 Affoltern am Albis, Switzerland.
2Children’s Research Center, Children’s University Hospital Zurich,
Steinwiesstrasse 75, CH-8032 Zurich, Switzerland. 3Department of Health
Sciences and Technology, ETH Zurich, Vladimir-Prelog-Weg 1-5/10, CH-8093
Zürich, Switzerland.
Received: 19 October 2016 Accepted: 28 June 2017
References
1. Dundar U, Toktas H, Solak O, Ulasli AM, Eroglu S. A comparative study of
conventional physiotherapy versus robotic training combined with
physiotherapy in patients with stroke. Top Stroke Rehabil. 2015;21(6):453–61.
2. Esclarín-Ruz A, Alcobendas-Maestro M, Casado-Lopez R, Perez-Mateos G,
Florido-Sanchez MA, Gonzalez-Valdizan E, et al. A comparison of robotic
walking therapy and conventional walking therapy in individuals with upper
versus lower motor neuron lesions: a randomized controlled trial. Arch Phys
Med Rehabil. 2014;95(6):1023–31.
3. Mehrholz J, Elsner B, Werner C, Kugler J, Pohl M. Electromechanical-assisted
training for walking after stroke: updated evidence. Stroke. 2013;44(10):e127–8.
4. Beretta E, Romei M, Molteni E, Avantaggiato P, Strazzer S. Combined
robotic-aided gait training and physical therapy improve functional abilities
and hip kinematics during gait in children and adolescents with acquired
brain injury. Brain Inj. 2015;29(7–8):955–62.
5. Schroeder AS, Homburg M, Warken B, Auffermann H, Koerte I, Berweck S, et
al. Prospective controlled cohort study to evaluate changes of function,
activity and participation in patients with bilateral spastic cerebral palsy
after robot-enhanced repetitive treadmill therapy. Eur J Paediatr Neurol.
2014;18(4):502–10.
6. Mayr A, Kofler M, Quirbach E, Matzak H, Fröhlich K, Saltuari L. Prospective,
blinded, randomized crossover study of gait rehabilitation in stroke patients
using the Lokomat gait orthosis. Neurorehabil Neural Repair. 2007;21(4):
307–14.
7. Schwartz I, Sajin A, Fisher I, Neeb M, Shochina M, Katz-Leurer M, et al. The
effectiveness of locomotor therapy using robotic-assisted gait training in
subacute stroke patients: a randomized controlled trial. PM R. 2009;
1(6):516–23.
8. Hidler J, Hamm LF, Lichy A, Groah SL. Automating activity-based interventions:
the role of robotics. J Rehabil Res Dev. 2008;45(2):337–44.
9. Hornby TG, Campbell DD, Kahn JH, Demott T, Moore JL, Roth HR. Enhanced
gait-related improvements after therapist- versus robotic-assisted locomotor
training in subjects with chronic stroke: a randomized controlled study.
Stroke. 2008;39(6):1786–92.
10. Dobkin BH, Duncan PW. Should body weight-supported treadmill training
and robotic-assistive steppers for locomotor training trot back to the
starting gate? Neurorehabil Neural Repair. 2012 May;26(4):308–17.
11. Labruyère R, van Hedel HJA. Strength training versus robot-assisted gait
training after incomplete spinal cord injury: a randomized pilot study in
patients depending on walking assistance. J Neuroeng Rehabil. 2014;11(1):4.
12. Reinkensmeyer DJ, Emken JL, Cramer SC. Robotics, motor learning, and
neurologic recovery. Annu Rev Biomed Eng. 2004 Jan;6:497–525.
13. Mirelman A, Bonato P, Deutsch JE. Effects of training with a robot-virtual
reality system compared with a robot alone on the gait of individuals after
stroke. Stroke. 2009;40(1):169–74.
14. Krishnan C, Ranganathan R, Dhaher YY, Rymer WZ. A pilot study on the
feasibility of robot-aided leg motor training to facilitate active participation.
PLoS One. 2013;8:10.
15. Hidler JM, Wall AE. Alterations in muscle activation patterns during robotic-
assisted walking. Clin Biomech. 2005;20(2):184–93.
16. Israel JF, Campbell DD, Kahn JH, Hornby TG. Metabolic costs and muscle
activity patterns during robotic- and therapist-assisted treadmill walking in
individuals with incomplete spinal cord injury. Phys Ther. 2006;86(11):1466–78.
17. Lotze M, Braun C, Birbaumer N, Anders S, Cohen LG. Motor learning elicited
by voluntary drive. Brain. 2003;126(4):866–72.
18. Kaelin-Lang A, Sawaki L, Cohen LG. Role of voluntary drive in encoding an
elementary motor memory. J Neurophysiol. 2005;93(2):1099–103.
19. Reinkensmeyer DJ, Akoner OM, Ferris DP, Gordon KE. Slacking by the
human motor system: Computational models and implications for robotic
orthoses. Proceedings of the Annual International Conference of the IEEE
Engineering in Medicine and Biology Society. 2009;2129–32.
20. Lewek MD, Cruz TH, Moore JL, Roth HR, Dhaher YY, Hornby TG. Allowing
Intralimb kinematic variability during Locomotor training Poststroke
improves kinematic consistency: a subgroup analysis from a randomized
clinical trial. Phys Ther. 2009;89(8):829–39.
21. Bernstein NA. The co-ordination and regulation of movements. Oxford:
Pergamon Press; 1967.
22. Cai LL, Fong AJ, Otoshi CK, Liang YQ, Cham JG, Zhong H, et al. Effects of
consistency vs. variability in robotically controlled training of stepping in
adult spinal mice. IEEE 9th International Conference on rehabilitation
robotics; 2005. p. 575–9.
23. Marchal-Crespo L, Reinkensmeyer DJ. Review of control strategies for
robotic movement training after neurologic injury. J Neuroeng Rehabil.
2009;6(1):20.
24. Colombo G, Joerg M, Schreier R, Dietz V. Treadmill training of
paraplegic patients using a robotic orthosis. J Rehabil Res Dev. 2000;
37(6):693–700.
25. Riener R, Lünenburger L, Jezernik S, Anderschitz M, Colombo G, Dietz V.
Patient-cooperative strategies for robot-aided treadmill training: first
experimental results. IEEE Trans Neural Syst Rehabil Eng. 2005;13(3):380–94.
26. Duschau-Wicke A, von Zitzewitz J, Caprez A, Lunenburger L, Riener R. Path
control: a method for patient-cooperative robot-aided gait rehabilitation.
IEEE Trans Neural Syst Rehabil Eng. 2010;18(1):38–48.
27. Schück A, Labruyère R, Vallery H, Riener R, Duschau-Wicke A. Feasibility and
effects of patient-cooperative robot-aided gait training applied in a 4-week
pilot trial. J Neuroeng Rehabil. 2012;9(1):31.
28. Cai LL, Fong AJ, Otoshi CK, Liang Y, Burdick JW, Roy RR, et al.
Implications of assist-as-needed robotic step training after a complete
spinal cord injury on intrinsic strategies of motor learning. J Neurosci.
2006;26(41):10564–8.
29. Banala SK, Kim SH, Agrawal SK, Scholz JP. Robot assisted gait training with active
leg exoskeleton (ALEX). IEEE Trans neural Syst Rehabil Eng. 2009;17(1):2–8.
30. Duschau-Wicke A, Caprez A, Riener R. Patient-cooperative control increases
active participation of individuals with SCI during robot-aided gait training.
J Neuroeng Rehabil. 2010;7:43.
Aurich-Schuler et al. Journal of NeuroEngineering and Rehabilitation  (2017) 14:76 Page 13 of 14
31. Duschau-Wicke A, Felsenstein S, Riener R. Adaptive body weight support
controls human activity during robot-aided gait training. 2009 IEEE
International Conference on rehabilitation robotics, ICORR 2009; 2009. p. 413–8.
32. Krishnan C, Kotsapouikis D, Dhaher YY, Rymer WZ. Reducing robotic
guidance during robot-assisted gait training improves gait function: a case
report on a stroke survivor. Arch Phys Med Rehabil. 2013;94(6):1202–6.
33. Koopman B, Meuleman JH, van Asseldonk EHF, van der Kooij H. Lateral
balance control for robotic gait training. IEEE Int conf Rehabil robot. 2013.
34. Veneman JF, Menger J, van Asseldonk EHF, van der Helm FCT, van der Kooij
H. Fixating the pelvis in the horizontal plane affects gait characteristics. Gait
Posture. 2008;28(1):157–63.
35. Zutter D, Hamann SL, Bichler L. Technischer Fortschritt in der Gangtherapie :
Rehaklinik Zihlschlacht und Hocoma bringen weltweit neues Lokomat
Modul zum klinischen Einsatz. http://www.hocoma.com. Accessibility lastly
checked 13 Mar 2014.
36. Liao HF, Jeng SF, Lai JS, Cheng CK, Hu MH. The relation between standing
balance and walking function in children with spastic diplegic cerebral
palsy. Dev Med Child Neurol. 1997;39(2):106–12.
37. Hocoma AG. Legal notes. http://www.hocoma.com. Accessibility lastly
checked 13 March 2014.
38. Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development
and reliability of a system to classify gross motor function in children with
cerebral palsy. Dev Med Child Neurol. 1997;39(4):214–23.
39. Hislop H, Brown M. Daniels and Worthingham’s muscle testing. 9th Edition.
Philadelphia: WB Saunders Co; 2013.
40. Fowler EG, Staudt LA, Greenberg MB, Oppenheim WL. Selective control
assessment of the lower extremity (SCALE): development, validation, and
interrater reliability of a clinical tool for patients with cerebral palsy. Dev
Med Child Neurol. 2009;51:607–14.
41. Colombo G, Wirz M, Dietz V. Driven gait orthosis for improvement of
locomotor training in paraplegic patients. Spinal Cord. 2001;3:252–5.
42. Riener R, Lünenburger L, Maier I, Colombo G, Dietz V. Locomotor training in
subjects with sensori-motor deficits: an overview of the robotic gait orthosis
Lokomat. J Healthc Eng. 2010;1(2):216.
43. Aurich-Schuler T, Warken B, Graser J V, Ulrich T, Borggraefe I, Heinen F, et al.
Practical recommendations for robot-assisted treadmill therapy (Lokomat) in
children with cerebral palsy: Indications, goal setting, and clinical
implementation within the WHO-ICF framework. Neuropediatrics. 2015;46(4):
248–60.
44. Urbaniak GC, Plous S. Research Randomizer V4.0. 2013. Available from:
http://www.randomizer.org/. Accessibility lastly checked 11 Oct 2016.
45. World Medical Association. World Medical association declaration of
Helsinki: ethical principles for Medical research involving human subjects.
Bulletin of the World Health Organization. 2001;79(4):373–4.
46. Hermens HJ, Freriks B, Disselhorst-Klug C, Rau G. Development of
recommendations for SEMG sensors and sensor placement procedures.
J Electromyogr Kinesiol. 2000;10(5):361–74.
47. Shiavi R, Frigo C, Pedotti A. Electromyographic signals during gait: criteria
for envelope filtering and number of strides. Med Biol Eng Comput. 1998;
36(2):171–8.
48. Chang W-N, Lipton JS, Tsirikos AI, Miller F. Kinesiological surface
electromyography in normal children: range of normal activity and pattern
analysis. J Electromyogr Kinesiol. 2007;17(4):437–45.
49. Rohatgi A. WebPlotDigitizer 3.10. Austin, Texas, USA. Available from: http://
arohatgi.info/WebPlotDigitizer. Accessibility lastly checked 11 Oct 2016.
50. Benjamini Y, Hochberg Y. Controlling the False Discovery rate: a practical
and powerful approach to multiple testing. J R Stat Soc Ser B Methodol.
1995;57(1):289–300.
51. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed.
Erlbaum L & A, editor. Routledge; 1988.
52. Evans JD. Straightforward statistics for the Behavioral Sciences. Brooks/Cole
pub. Pacific Grove: Co: An International Thomsom Publ. Co; 1996.
53. van Kammen K, Boonstra AM, van der Woude LHV, Reinders-Messelink HA,
den Otter R. The combined effects of guidance force, bodyweight support
and gait speed on muscle activity during able-bodied walking in the
Lokomat. Clin Biomech. 2016;36:65–73.
54. Duschau-Wicke AHB. Patient-cooperative robot-aided gait rehabilitation.
DISS. ETH NO. 19300. Zurich, Switzerland; 2010.
55. Agostini V, Nascimbeni A, Gaffuri A, Imazio P, Benedetti MG, Knaflitz M, et al.
Gait & Posture Normative EMG activation patterns of school-age children
during gait. Gait Posture. 2010;32(3):285–9.
56. Aurich-Schuler T, Müller R, van Hedel HJA. Leg surface electromyography
patterns in children with neuro-orthopedic disorders walking on a treadmill
unassisted and assisted by a robot with and without encouragement. J
Neuroeng Rehabil. 2013;10:78.
57. Brunner R, Romkes J. Abnormal EMG muscle activity during gait in patients
without neurological disorders. Gait Posture. 2008;27(3):399–407.
58. Moreno JC, Barroso F, Farina D, Gizzi L, Santos C, Molinari M, et al. Effects of
robotic guidance on the coordination of locomotion. J Neuroeng Rehabil.
2013;10:79.
59. Aoyagi D, Ichinose WE, Harkema SJ, Reinkensmeyer DJ, Bobrow JE. A robot
and control algorithm that can synchronously assist in naturalistic motion
during body-weight-supported gait training following neurologic injury.
IEEE Trans neural Syst Rehabil Eng. 2007;15(3):387–400.
60. Huang VS, Krakauer JW. Robotic neurorehabilitation: a computational motor
learning perspective. J Neuroeng Rehabil. 2009;6:5.
61. van Hedel HJA, Tomatis L, Müller R. Modulation of leg muscle activity and
gait kinematics by walking speed and bodyweight unloading. Gait Posture.
2006;24(1):35–45.
62. von Zitzewitz J, Bernhardt M, Riener R. A novel method for automatic treadmill
speed adaptation. IEEE Trans neural Syst Rehabil Eng. 2007;15(3):401–9.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Aurich-Schuler et al. Journal of NeuroEngineering and Rehabilitation  (2017) 14:76 Page 14 of 14
